dMed Biopharmaceutical Co., Ltd.
dMed, a “Next Generation” full service CRO, provides industry solutions to pharmaceutical and medical device companies in China and across the globe. dMed is uniquely positioned to leverage China’s new regulatory framework, offer innovative drug development strategies, and help clients expand globally by tapping into the world’s second largest pharmaceutical market. dMed works with its partners to accelerate therapies and products into the clinic while helping to build internal capabilities.